Strategy.
Overview
Frontier Pharma targets investment opportunities with enterprise values between $15 million and $100 million however has the flexibility to consider other deal sizes.
We are typically long-term investors without a defined exit horizon.
We seek opportunities where our technical & commercial expertise may be leveraged to create value, through operational improvements, restructuring, internationalisation and business development. Our focus areas can be found below:
Sectors
Branded Generics
Established brands
Consumer Health (OTC)
Biologics
Capabilities
Strong local & international compliance track record
Advanced capabilities (e.g. sterile, controlled release)
Competitive production costs
Mid to high capacity utilisation with room for expansion
Portfolio
Differentiated and niche portfolio
Valued and trusted brands, beacons of quality
Internationally diversified or well suited for export markets
Financials
Track record for growth or in a high growth market
Profitable or prospect of near-term profitability
Well-invested operations
Culture
Culture of excellence, team-work, trust & innovation
Strong reputation for quality, compliance & reliability
Able to work constructively with partners